Napolitano Janet 4
4 · Vir Biotechnology, Inc. · Filed Jun 2, 2025
Insider Transaction Report
Form 4
Napolitano Janet
Director
Transactions
- Sale
Common Stock
2025-06-02$5.05/sh−3,200$16,149→ 16,416 total - Award
Common Stock
2025-05-30+8,000→ 19,616 total - Award
Stock Option (Right to Buy)
2025-05-30+16,000→ 16,000 totalExercise: $4.94From: 2026-05-30Exp: 2035-05-29→ Common Stock (16,000 underlying)
Footnotes (5)
- [F1]Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
- [F2]The RSUs will vest in full on May 30, 2026.
- [F3]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2024.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.845 to $5.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F5]The shares subject to the stock option will vest and become exercisable in full on May 30, 2026.